4D Molecular Therapeutics, Inc.
Top stories
Latest
- 8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)SEC EDGAR (current filings · 2026-09-28 12:05 UTC · story
- 4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DMEGlobeNewswire — all · 2026-09-28 12:00 UTC · story